Quarterly report pursuant to Section 13 or 15(d)

Supplemental Balance Sheet Information (Tables)

v3.22.2.2
Supplemental Balance Sheet Information (Tables)
9 Months Ended
Sep. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of accrued expenses and other current liabilities

Accrued expenses and other current liabilities consist of the following:

 

 

 

September 30,
2022

 

 

December 31,
2021

 

Accrued consulting

 

$

229,661

 

 

$

210,000

 

Accrued compensation

 

 

417,573

 

 

 

421,734

 

Deferred revenue

 

 

23,683

 

 

 

 

Accrued research and development

 

 

1,586,138

 

 

 

2,077,932

 

Accrued interest

 

 

 

 

 

968

 

Accrued other

 

 

32,671

 

 

 

5,127

 

Total accrued expenses and other current liabilities

 

$

2,289,726

 

 

$

2,715,761